Assembly Biosciences, Inc. Financing Cash Flow
Assembly Biosciences, Inc. (ASMB) reported Financing Cash Flow of $108.88 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-13
- Assembly Biosciences, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $108.73M, a 30357.98% increase year-over-year.
- Assembly Biosciences, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $149.00K, a 92.25% decline year-over-year.
- Assembly Biosciences, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $456.00K, a 97.32% decline year-over-year.
- Assembly Biosciences, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $171.93M.
- Assembly Biosciences, Inc. net cash provided by (used in) financing activities for fiscal 2025 was $174.67M, a 493.12% increase from fiscal 2024.
- Assembly Biosciences, Inc. net cash provided by (used in) financing activities for fiscal 2024 was $29.45M, a 113.12% increase from fiscal 2023.
- Assembly Biosciences, Inc. net cash provided by (used in) financing activities for fiscal 2023 was $13.82M, a 2150.49% increase from fiscal 2022.
- Assembly Biosciences, Inc. net cash provided by (used in) financing activities for fiscal 2022 was $614.00K, a 98.84% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 3 month as first filed | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 6 month as first filed | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 9 month as first filed | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 12 month as first filed | Net Cash Provided by (Used in) Financing Activities 69 month | Net Cash Provided by (Used in) Financing Activities 72 month | Net Cash Provided by (Used in) Financing Activities 75 month | Net Cash Provided by (Used in) Financing Activities 78 month | Net Cash Provided by (Used in) Financing Activities 81 month | Net Cash Provided by (Used in) Financing Activities 84 month | Net Cash Provided by (Used in) Financing Activities 87 month | Net Cash Provided by (Used in) Financing Activities 90 month | Net Cash Provided by (Used in) Financing Activities 93 month | Net Cash Provided by (Used in) Financing Activities 96 month | Net Cash Provided by (Used in) Financing Activities 99 month | Net Cash Provided by (Used in) Financing Activities 102 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $108.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $108.88M 10-Q · filed 2026-08-13 | $109.34M derived: sum of 3 quarters · filed 2026-08-13 | $281.27M derived: sum of 4 quarters · filed 2026-08-13 | ||||||||||||||||
| 2026-03-31 | $149.00K 10-Q · filed 2026-05-07 | $605.00K derived: sum of 2 quarters · filed 2026-05-07 | $172.54M derived: sum of 3 quarters · filed 2026-05-07 | $172.89M derived: sum of 4 quarters · filed 2026-08-13 | ||||||||||||||||
| 2025-12-31 | $456.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $172.39M derived: sum of 2 quarters · filed 2026-03-19 | $172.75M derived: sum of 3 quarters · filed 2026-08-13 | $174.67M 10-K · filed 2026-03-19 | ||||||||||||||||
| 2025-09-30 | $171.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $172.29M derived: sum of 2 quarters · filed 2026-08-13 | $174.21M 10-Q · filed 2025-11-10 | $191.21M derived: sum of 4 quarters · filed 2026-08-13 | ||||||||||||||||
| 2025-06-30 | $357.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $2.28M 10-Q · filed 2026-08-13 | $19.27M derived: sum of 3 quarters · filed 2026-08-13 | $19.27M derived: sum of 4 quarters · filed 2026-08-13 | ||||||||||||||||
| 2025-03-31 | $1.92M 10-Q · filed 2026-05-07 | $18.92M derived: sum of 2 quarters · filed 2026-05-07 | $18.92M derived: sum of 3 quarters · filed 2026-05-07 | $31.37M derived: sum of 4 quarters · filed 2026-05-07 | ||||||||||||||||
| 2024-12-31 | $17.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $17.00M derived: sum of 2 quarters · filed 2026-03-19 | $29.45M derived: sum of 3 quarters · filed 2026-03-19 | $29.45M 10-K · filed 2026-03-19 | ||||||||||||||||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $12.45M derived: sum of 2 quarters · filed 2025-11-10 | $12.45M 10-Q · filed 2025-11-10 | $21.65M derived: sum of 4 quarters · filed 2025-11-10 | ||||||||||||||||
| 2024-06-30 | $12.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $12.45M 10-Q · filed 2025-08-06 | $21.65M derived: sum of 3 quarters · filed 2025-08-06 | $21.65M derived: sum of 4 quarters · filed 2025-08-06 | ||||||||||||||||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-08 | $9.19M derived: sum of 2 quarters · filed 2025-05-08 | $9.19M derived: sum of 3 quarters · filed 2025-05-08 | $9.33M derived: sum of 4 quarters · filed 2025-05-08 | ||||||||||||||||
| 2023-12-31 | $9.19M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $9.19M derived: sum of 2 quarters · filed 2025-03-20 | $9.33M derived: sum of 3 quarters · filed 2025-03-20 | $13.82M 10-K · filed 2025-03-20 | ||||||||||||||||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $134.00K derived: sum of 2 quarters · filed 2024-11-07 | $4.63M 10-Q · filed 2024-11-07 | $5.06M derived: sum of 4 quarters · filed 2024-11-07 | ||||||||||||||||
| 2023-06-30 | $134.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $4.63M 10-Q · filed 2024-08-08 | $5.06M derived: sum of 3 quarters · filed 2024-08-08 | $5.06M derived: sum of 4 quarters · filed 2024-08-08 | ||||||||||||||||
| 2023-03-31 | $4.49M 10-Q · filed 2024-05-08 | $4.93M derived: sum of 2 quarters · filed 2024-05-08 | $4.93M derived: sum of 3 quarters · filed 2024-05-08 | $5.11M derived: sum of 4 quarters · filed 2024-05-08 | ||||||||||||||||
| 2022-12-31 | $437.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $437.00K derived: sum of 2 quarters · filed 2024-03-28 | $614.00K derived: sum of 3 quarters · filed 2024-03-28 | $614.00K 10-K · filed 2024-03-28 | ||||||||||||||||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $177.00K derived: sum of 2 quarters · filed 2023-11-08 | $177.00K 10-Q · filed 2023-11-08 | $2.89M derived: sum of 4 quarters · filed 2023-11-08 | ||||||||||||||||
| 2022-06-30 | $177.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $177.00K 10-Q · filed 2023-08-09 | $2.89M derived: sum of 3 quarters · filed 2023-08-09 | $12.95M derived: sum of 4 quarters · filed 2023-08-09 | ||||||||||||||||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-04 | $2.71M derived: sum of 2 quarters · filed 2023-05-04 | $12.77M derived: sum of 3 quarters · filed 2023-05-04 | $18.93M derived: sum of 4 quarters · filed 2023-05-04 | ||||||||||||||||
| 2021-12-31 | $2.71M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $12.77M derived: sum of 2 quarters · filed 2023-03-22 | $18.93M derived: sum of 3 quarters · filed 2023-03-22 | $53.06M 10-K · filed 2023-03-22 | ||||||||||||||||
| 2021-09-30 | $10.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $16.21M derived: sum of 2 quarters · filed 2022-11-08 | $50.35M 10-Q · filed 2022-11-08 | $56.04M derived: sum of 4 quarters · filed 2022-11-08 | ||||||||||||||||
| 2021-06-30 | $6.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $40.30M 10-Q · filed 2022-08-09 | $45.98M derived: sum of 3 quarters · filed 2022-08-09 | $46.83M derived: sum of 4 quarters · filed 2022-08-09 | ||||||||||||||||
| 2021-03-31 | $34.14M 10-Q · filed 2022-05-12 | $39.82M derived: sum of 2 quarters · filed 2022-05-12 | $40.67M derived: sum of 3 quarters · filed 2022-05-12 | $41.62M derived: sum of 4 quarters · filed 2022-05-12 | ||||||||||||||||
| 2020-12-31 | $5.69M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $6.53M derived: sum of 2 quarters · filed 2022-03-11 | $7.48M derived: sum of 3 quarters · filed 2022-03-11 | $7.60M 10-K · filed 2022-03-11 | ||||||||||||||||
| 2020-09-30 | $843.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $1.79M derived: sum of 2 quarters · filed 2021-11-04 | $1.91M 10-Q · filed 2021-11-04 | $139.33M derived: sum of 4 quarters · filed 2021-11-04 | ||||||||||||||||
| 2020-06-30 | $950.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $1.07M 10-Q · filed 2021-08-05 | $138.48M derived: sum of 3 quarters · filed 2021-08-05 | $139.87M derived: sum of 4 quarters · filed 2021-08-05 | ||||||||||||||||
| 2020-03-31 | $119.00K 10-Q · filed 2021-05-06 | $137.53M derived: sum of 2 quarters · filed 2021-05-06 | $138.92M derived: sum of 3 quarters · filed 2021-05-06 | $139.63M derived: sum of 4 quarters · filed 2021-05-06 | ||||||||||||||||
| 2019-12-31 | $137.41M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $138.80M derived: sum of 2 quarters · filed 2021-02-25 | $139.51M derived: sum of 3 quarters · filed 2021-02-25 | $139.65M 10-K · filed 2021-02-25 | ||||||||||||||||
| 2019-09-30 | $1.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $2.09M derived: sum of 2 quarters · filed 2020-11-05 | $2.23M 10-Q · filed 2020-11-05 | $2.84M derived: sum of 4 quarters · filed 2021-02-25 | ||||||||||||||||
| 2019-06-30 | $706.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $846.00K 10-Q · filed 2020-08-05 | $1.45M derived: sum of 3 quarters · filed 2021-02-25 | $157.29M derived: sum of 4 quarters · filed 2021-02-25 | ||||||||||||||||
| 2019-03-31 | $140.00K 10-Q · filed 2020-05-08 | $745.00K derived: sum of 2 quarters · filed 2021-02-25 | $156.59M derived: sum of 3 quarters · filed 2021-02-25 | $158.44M derived: sum of 4 quarters · filed 2021-02-25 | ||||||||||||||||
| 2018-12-31 | $605.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $156.45M derived: sum of 2 quarters · filed 2021-02-25 | $158.30M derived: sum of 3 quarters · filed 2021-02-25 | $159.79M 10-K · filed 2021-02-25 | ||||||||||||||||
| 2018-09-30 | $155.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $157.69M derived: sum of 2 quarters · filed 2019-11-07 | $159.19M 10-Q · filed 2019-11-07 | $159.19M 10-Q · filed 2018-11-08 | $225.42M derived: sum of 4 quarters · filed 2020-03-04 | |||||||||||||||
| 2018-06-30 | $1.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-05 | $3.34M 10-Q · filed 2019-08-05 | $3.34M 10-Q · filed 2018-08-08 | $69.57M derived: sum of 3 quarters · filed 2020-03-04 | $69.84M derived: sum of 4 quarters · filed 2020-03-04 | |||||||||||||||
| 2018-03-31 | $1.49M 10-Q · filed 2019-05-09 | $1.49M 10-Q · filed 2018-05-07 | $67.72M derived: sum of 2 quarters · filed 2020-03-04 | $67.99M derived: sum of 3 quarters · filed 2020-03-04 | $68.09M derived: sum of 4 quarters · filed 2020-03-04 | |||||||||||||||
| 2017-12-31 | $66.23M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-04 | $66.49M derived: sum of 2 quarters · filed 2020-03-04 | $66.60M derived: sum of 3 quarters · filed 2020-03-04 | $67.24M 10-K · filed 2020-03-04 | $67.24M 10-K · filed 2018-03-08 | |||||||||||||||
| 2017-09-30 | $262.88K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $370.92K derived: sum of 2 quarters · filed 2018-11-08 | $1.01M 10-Q · filed 2018-11-08 | $1.16M derived: sum of 4 quarters · filed 2019-02-28 | ||||||||||||||||
| 2017-06-30 | $108.04K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $748.06K 10-Q · filed 2018-08-08 | $901.06K derived: sum of 3 quarters · filed 2019-02-28 | |||||||||||||||||
| 2017-03-31 | $640.02K 10-Q · filed 2018-05-07 | $793.02K derived: sum of 2 quarters · filed 2019-02-28 | ||||||||||||||||||
| 2016-12-31 | $153.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $153.00K 10-K · filed 2019-02-28 | $152.64K 10-K · filed 2018-03-08 | |||||||||||||||||
| 2016-09-30 | $0.00 10-Q · filed 2017-11-01 | |||||||||||||||||||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $257.44K derived: sum of 2 quarters · filed 2018-03-08 | $10.90M derived: sum of 3 quarters · filed 2018-03-08 | $81.57M 10-K · filed 2018-03-08 | ||||||||||||||||
| 2015-09-30 | $257.44K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $10.90M derived: sum of 2 quarters · filed 2015-11-09 | $81.57M 10-Q · filed 2015-11-09 | $96.53M derived: sum of 4 quarters · filed 2015-11-09 | ||||||||||||||||
| 2015-06-30 | $10.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | $81.31M 10-Q · filed 2015-08-13 | $96.27M derived: sum of 3 quarters · filed 2015-08-13 | $96.27M derived: sum of 4 quarters · filed 2015-11-09 | ||||||||||||||||
| 2015-03-31 | $70.67M 10-Q · filed 2015-05-08 | $85.63M derived: sum of 2 quarters · filed 2015-05-08 | $85.63M derived: sum of 3 quarters · filed 2015-11-09 | $85.63M derived: sum of 4 quarters · filed 2015-11-09 | ||||||||||||||||
| 2014-12-31 | $14.96M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $14.96M derived: sum of 2 quarters · filed 2015-11-09 | $14.96M derived: sum of 3 quarters · filed 2015-11-09 | $16.73M 10-K · filed 2015-03-16 | ||||||||||||||||
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $0.00 derived: sum of 2 quarters · filed 2015-11-09 | $1.76M 10-Q · filed 2015-11-09 | $2.00M derived: sum of 4 quarters · filed 2015-11-09 | ||||||||||||||||
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | $1.76M 10-Q · filed 2015-08-13 | $2.00M derived: sum of 3 quarters · filed 2015-08-13 | $5.38M derived: sum of 4 quarters · filed 2015-08-13 | ||||||||||||||||
| 2014-03-31 | $1.76M 10-Q · filed 2015-05-08 | $2.00M derived: sum of 2 quarters · filed 2015-05-08 | $5.38M derived: sum of 3 quarters · filed 2015-05-08 | $5.38M derived: sum of 4 quarters · filed 2015-05-08 | $108.49M 10-Q · filed 2014-05-14 | |||||||||||||||
| 2013-12-31 | $232.10K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $3.62M derived: sum of 2 quarters · filed 2015-03-16 | $3.62M derived: sum of 3 quarters · filed 2015-03-16 | $24.37M 10-K · filed 2015-03-16 | $106.72M 10-K · filed 2014-03-31 | |||||||||||||||
| 2013-09-30 | $3.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-17 | $3.39M derived: sum of 2 quarters · filed 2014-11-17 | $24.14M 10-Q · filed 2014-11-17 | $24.14M derived: sum of 4 quarters · filed 2014-11-17 | $106.49M 10-Q · filed 2013-11-12 | |||||||||||||||
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | $20.75M 10-Q · filed 2014-08-14 | $20.75M derived: sum of 3 quarters · filed 2014-08-14 | $20.75M derived: sum of 4 quarters · filed 2014-08-14 | $103.10M 10-Q · filed 2013-08-09 | |||||||||||||||
| 2013-03-31 | $20.75M 10-Q · filed 2014-05-14 | $20.75M derived: sum of 2 quarters · filed 2014-05-14 | $20.75M derived: sum of 3 quarters · filed 2014-05-14 | $25.47M derived: sum of 4 quarters · filed 2014-05-14 | $103.10M 10-Q · filed 2013-05-10 | |||||||||||||||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $0.00 derived: sum of 2 quarters · filed 2014-03-31 | $4.72M derived: sum of 3 quarters · filed 2014-03-31 | $4.90M 10-K · filed 2014-03-31 | $82.35M 10-K · filed 2013-03-18 | |||||||||||||||
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $4.72M derived: sum of 2 quarters · filed 2013-11-12 | $4.90M 10-Q · filed 2013-11-12 | $4.91M derived: sum of 4 quarters · filed 2013-11-12 | $82.35M 10-Q · filed 2012-11-13 | |||||||||||||||
| 2012-06-30 | $4.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $4.90M 10-Q · filed 2013-08-09 | $4.91M derived: sum of 3 quarters · filed 2013-08-09 | $50.91M derived: sum of 4 quarters · filed 2013-08-09 | $82.35M 10-Q · filed 2012-08-09 | |||||||||||||||
| 2012-03-31 | $180.73K 10-Q · filed 2013-05-10 | $194.48K derived: sum of 2 quarters · filed 2013-05-10 | $46.19M derived: sum of 3 quarters · filed 2013-05-10 | $46.41M derived: sum of 4 quarters · filed 2013-05-10 | $77.63M 10-Q · filed 2012-05-09 | |||||||||||||||
| 2011-12-31 | $13.75K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $46.01M derived: sum of 2 quarters · filed 2013-03-18 | $46.23M derived: sum of 3 quarters · filed 2013-03-18 | $47.49M 10-K · filed 2013-03-18 | $77.45M 10-K · filed 2012-03-14 | |||||||||||||||
| 2011-09-30 | $46.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-13 | $46.22M derived: sum of 2 quarters · filed 2012-11-13 | $47.47M 10-Q · filed 2012-11-13 | $62.99M derived: sum of 4 quarters · filed 2013-03-18 | $77.44M 10-Q/A · filed 2011-11-18 | |||||||||||||||
| 2011-06-30 | $219.98K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $1.48M 10-Q · filed 2012-08-09 | $16.99M derived: sum of 3 quarters · filed 2013-03-18 | $17.64M derived: sum of 4 quarters · filed 2013-03-18 | $31.44M 10-Q · filed 2011-08-15 | |||||||||||||||
| 2011-03-31 | $1.26M 10-Q · filed 2012-05-09 | $16.77M derived: sum of 2 quarters · filed 2013-03-18 | $17.42M derived: sum of 3 quarters · filed 2013-03-18 | |||||||||||||||||
| 2010-12-31 | $15.52M derived: 10-K 12 month − 10-Q/A 9 month · filed 2013-03-18 | $16.16M derived: sum of 2 quarters · filed 2013-03-18 | $19.70M 10-K · filed 2013-03-18 | |||||||||||||||||
| 2010-09-30 | $642.50K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2011-11-18 | $4.19M 10-Q/A · filed 2011-11-18 | ||||||||||||||||||
| 2010-06-30 | $3.54M 10-Q · filed 2011-08-15 | |||||||||||||||||||
| 2009-12-31 | $3.55M 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |